| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Software | 15 | 2025 | 400 | 4.010 |
Why?
|
| CRISPR-Cas Systems | 17 | 2026 | 368 | 2.370 |
Why?
|
| Transcription Factors | 32 | 2025 | 1552 | 2.200 |
Why?
|
| Computational Biology | 11 | 2020 | 367 | 2.180 |
Why?
|
| Sequence Analysis, DNA | 5 | 2025 | 414 | 1.840 |
Why?
|
| Gene Editing | 12 | 2026 | 327 | 1.500 |
Why?
|
| Polyadenylation | 3 | 2024 | 51 | 1.260 |
Why?
|
| Zebrafish | 11 | 2025 | 369 | 1.260 |
Why?
|
| Animals | 111 | 2026 | 21308 | 1.250 |
Why?
|
| Transcriptome | 7 | 2020 | 399 | 1.220 |
Why?
|
| Cell Line, Tumor | 41 | 2026 | 1566 | 1.180 |
Why?
|
| Mice | 74 | 2026 | 11097 | 1.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2025 | 312 | 1.020 |
Why?
|
| Sequence Analysis, RNA | 6 | 2024 | 180 | 1.020 |
Why?
|
| Molecular Sequence Annotation | 4 | 2020 | 67 | 0.990 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 2025 | 234 | 0.980 |
Why?
|
| Pancreatic Neoplasms | 7 | 2026 | 354 | 0.950 |
Why?
|
| DNA | 11 | 2025 | 858 | 0.940 |
Why?
|
| Gene Expression Profiling | 11 | 2021 | 794 | 0.940 |
Why?
|
| Bromodeoxyuridine | 1 | 2025 | 44 | 0.930 |
Why?
|
| Databases, Genetic | 5 | 2017 | 90 | 0.920 |
Why?
|
| Genome | 9 | 2025 | 285 | 0.920 |
Why?
|
| Signal Transduction | 33 | 2026 | 3144 | 0.860 |
Why?
|
| Carcinoma, Pancreatic Ductal | 5 | 2026 | 128 | 0.840 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2025 | 449 | 0.830 |
Why?
|
| Proteomics | 4 | 2020 | 292 | 0.820 |
Why?
|
| Gene Expression Regulation | 14 | 2021 | 1630 | 0.820 |
Why?
|
| Chromatin Immunoprecipitation | 7 | 2020 | 146 | 0.780 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2013 | 297 | 0.760 |
Why?
|
| DNA-Binding Proteins | 12 | 2024 | 1224 | 0.750 |
Why?
|
| Humans | 101 | 2026 | 65100 | 0.740 |
Why?
|
| Saccharomyces cerevisiae | 7 | 2025 | 570 | 0.710 |
Why?
|
| RNA | 3 | 2025 | 426 | 0.710 |
Why?
|
| Adipose Tissue, White | 6 | 2026 | 92 | 0.700 |
Why?
|
| DNA Replication | 7 | 2025 | 247 | 0.690 |
Why?
|
| Computer Graphics | 2 | 2019 | 19 | 0.680 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2025 | 112 | 0.670 |
Why?
|
| Nucleotide Motifs | 2 | 2018 | 52 | 0.630 |
Why?
|
| Stress, Physiological | 5 | 2025 | 209 | 0.620 |
Why?
|
| Amino Acids | 2 | 2020 | 148 | 0.620 |
Why?
|
| Binding Sites | 10 | 2021 | 921 | 0.610 |
Why?
|
| Triple Negative Breast Neoplasms | 4 | 2025 | 71 | 0.590 |
Why?
|
| Metabolomics | 1 | 2019 | 62 | 0.580 |
Why?
|
| Mitochondria | 6 | 2024 | 403 | 0.580 |
Why?
|
| RNA, Messenger | 9 | 2026 | 1575 | 0.570 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2025 | 440 | 0.570 |
Why?
|
| Cell Cycle | 7 | 2025 | 398 | 0.560 |
Why?
|
| Gene Expression Regulation, Developmental | 10 | 2021 | 662 | 0.560 |
Why?
|
| Prostatic Neoplasms | 5 | 2026 | 493 | 0.550 |
Why?
|
| Adipose Tissue, Brown | 5 | 2026 | 124 | 0.550 |
Why?
|
| Cell Proliferation | 15 | 2024 | 1036 | 0.550 |
Why?
|
| RNA Editing | 2 | 2016 | 24 | 0.550 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2025 | 583 | 0.540 |
Why?
|
| Neuropilin-2 | 4 | 2024 | 40 | 0.530 |
Why?
|
| Deoxyribonucleases | 2 | 2017 | 32 | 0.530 |
Why?
|
| Chromatin | 9 | 2025 | 641 | 0.520 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2025 | 318 | 0.510 |
Why?
|
| Proteins | 2 | 2020 | 764 | 0.510 |
Why?
|
| Transcription, Genetic | 10 | 2021 | 907 | 0.500 |
Why?
|
| Statistics as Topic | 1 | 2017 | 147 | 0.500 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2024 | 49 | 0.490 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2025 | 218 | 0.490 |
Why?
|
| Drosophila Proteins | 4 | 2024 | 758 | 0.490 |
Why?
|
| Membrane Proteins | 8 | 2025 | 918 | 0.480 |
Why?
|
| X Chromosome Inactivation | 4 | 2025 | 60 | 0.480 |
Why?
|
| Rett Syndrome | 3 | 2025 | 8 | 0.480 |
Why?
|
| Caenorhabditis elegans | 6 | 2022 | 706 | 0.480 |
Why?
|
| Caenorhabditis elegans Proteins | 5 | 2022 | 447 | 0.480 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2026 | 58 | 0.470 |
Why?
|
| MicroRNAs | 6 | 2025 | 710 | 0.460 |
Why?
|
| Base Sequence | 9 | 2022 | 1329 | 0.450 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 349 | 0.450 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2021 | 226 | 0.430 |
Why?
|
| Genomic Instability | 3 | 2025 | 59 | 0.430 |
Why?
|
| Adipokines | 2 | 2026 | 36 | 0.430 |
Why?
|
| Calcineurin | 3 | 2025 | 47 | 0.420 |
Why?
|
| Protein Binding | 15 | 2020 | 1639 | 0.420 |
Why?
|
| Enhancer Elements, Genetic | 4 | 2020 | 119 | 0.420 |
Why?
|
| Cell Differentiation | 10 | 2022 | 1386 | 0.410 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2019 | 343 | 0.410 |
Why?
|
| Mouse Embryonic Stem Cells | 3 | 2020 | 28 | 0.410 |
Why?
|
| 3' Flanking Region | 1 | 2013 | 8 | 0.400 |
Why?
|
| Ovarian Neoplasms | 2 | 2025 | 166 | 0.390 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2024 | 191 | 0.390 |
Why?
|
| HEK293 Cells | 13 | 2022 | 615 | 0.390 |
Why?
|
| Stem Cells | 4 | 2022 | 276 | 0.380 |
Why?
|
| Apoptosis | 8 | 2024 | 1100 | 0.380 |
Why?
|
| Zebrafish Proteins | 6 | 2019 | 168 | 0.380 |
Why?
|
| Cell Cycle Proteins | 7 | 2025 | 402 | 0.380 |
Why?
|
| Mitochondrial Proteins | 4 | 2022 | 108 | 0.380 |
Why?
|
| Rad51 Recombinase | 2 | 2025 | 32 | 0.380 |
Why?
|
| Fibroblasts | 5 | 2025 | 422 | 0.380 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2020 | 50 | 0.370 |
Why?
|
| Drosophila melanogaster | 4 | 2024 | 559 | 0.370 |
Why?
|
| Oxidative Phosphorylation | 2 | 2022 | 42 | 0.370 |
Why?
|
| Neoplasms | 6 | 2023 | 1367 | 0.360 |
Why?
|
| Endonucleases | 4 | 2022 | 84 | 0.360 |
Why?
|
| Homeodomain Proteins | 4 | 2019 | 277 | 0.350 |
Why?
|
| Tumor Microenvironment | 4 | 2026 | 182 | 0.350 |
Why?
|
| Nanoparticles | 4 | 2026 | 544 | 0.330 |
Why?
|
| Drosophila | 2 | 2013 | 480 | 0.330 |
Why?
|
| Liver | 6 | 2022 | 869 | 0.330 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2019 | 70 | 0.330 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2025 | 64 | 0.330 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2010 | 38 | 0.330 |
Why?
|
| Neoplastic Stem Cells | 4 | 2024 | 195 | 0.320 |
Why?
|
| Oxidative Stress | 3 | 2024 | 320 | 0.320 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2016 | 205 | 0.320 |
Why?
|
| Nuclear Proteins | 8 | 2025 | 790 | 0.320 |
Why?
|
| Mutation | 10 | 2025 | 2658 | 0.320 |
Why?
|
| Urea | 2 | 2000 | 41 | 0.320 |
Why?
|
| Genomics | 4 | 2020 | 384 | 0.310 |
Why?
|
| Breast Neoplasms | 8 | 2020 | 1222 | 0.310 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 3 | 2025 | 15 | 0.300 |
Why?
|
| Melanoma | 3 | 2019 | 333 | 0.300 |
Why?
|
| Ki-67 Antigen | 2 | 2021 | 37 | 0.300 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 4 | 2023 | 82 | 0.300 |
Why?
|
| Heterochromatin | 3 | 2020 | 98 | 0.300 |
Why?
|
| Dexamethasone | 2 | 2021 | 213 | 0.300 |
Why?
|
| DNA Transposable Elements | 3 | 2021 | 159 | 0.290 |
Why?
|
| BRCA1 Protein | 3 | 2025 | 68 | 0.290 |
Why?
|
| Cell Nucleolus | 2 | 2020 | 71 | 0.290 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 2025 | 52 | 0.290 |
Why?
|
| Energy Metabolism | 4 | 2026 | 396 | 0.290 |
Why?
|
| Phosphorylation | 9 | 2025 | 961 | 0.280 |
Why?
|
| Forkhead Transcription Factors | 3 | 2023 | 132 | 0.280 |
Why?
|
| Polycomb Repressive Complex 1 | 3 | 2018 | 31 | 0.280 |
Why?
|
| Radiation Tolerance | 2 | 2025 | 56 | 0.280 |
Why?
|
| Insulin | 3 | 2026 | 695 | 0.280 |
Why?
|
| Embryo, Nonmammalian | 4 | 2019 | 183 | 0.280 |
Why?
|
| Sphingolipids | 2 | 2025 | 24 | 0.270 |
Why?
|
| Glucose | 3 | 2026 | 476 | 0.270 |
Why?
|
| Cellular Senescence | 2 | 2026 | 120 | 0.270 |
Why?
|
| Cell Movement | 5 | 2025 | 480 | 0.270 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2025 | 33 | 0.270 |
Why?
|
| Arteries | 2 | 2020 | 81 | 0.270 |
Why?
|
| Zinc Fingers | 4 | 2015 | 105 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 8 | 2018 | 687 | 0.270 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2016 | 80 | 0.260 |
Why?
|
| Fusion Proteins, bcr-abl | 4 | 2019 | 35 | 0.260 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2016 | 210 | 0.260 |
Why?
|
| Cells, Cultured | 11 | 2025 | 2188 | 0.260 |
Why?
|
| Tyrosinemias | 2 | 2019 | 20 | 0.260 |
Why?
|
| Activating Transcription Factors | 3 | 2012 | 11 | 0.260 |
Why?
|
| Cell Line | 10 | 2023 | 2023 | 0.260 |
Why?
|
| Lipids | 3 | 2026 | 328 | 0.260 |
Why?
|
| Wnt Proteins | 2 | 2018 | 104 | 0.260 |
Why?
|
| Chromosome Inversion | 2 | 2024 | 18 | 0.250 |
Why?
|
| Female | 30 | 2026 | 34000 | 0.250 |
Why?
|
| Mice, Knockout | 11 | 2021 | 2155 | 0.250 |
Why?
|
| Neoplasm Proteins | 4 | 2024 | 285 | 0.250 |
Why?
|
| Histones | 7 | 2025 | 494 | 0.250 |
Why?
|
| Serine C-Palmitoyltransferase | 2 | 2025 | 17 | 0.250 |
Why?
|
| Receptors, Notch | 4 | 2017 | 110 | 0.240 |
Why?
|
| Cell Division | 3 | 2025 | 449 | 0.240 |
Why?
|
| Trans-Activators | 5 | 2019 | 320 | 0.240 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 2 | 2024 | 22 | 0.240 |
Why?
|
| Acyltransferases | 2 | 2024 | 32 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 13 | 2026 | 3470 | 0.240 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2016 | 19 | 0.240 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 345 | 0.240 |
Why?
|
| Repressor Proteins | 4 | 2021 | 351 | 0.240 |
Why?
|
| Disease Models, Animal | 11 | 2026 | 2284 | 0.240 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2026 | 22 | 0.230 |
Why?
|
| Thiolester Hydrolases | 1 | 2025 | 10 | 0.230 |
Why?
|
| Stromal Cells | 1 | 2026 | 78 | 0.230 |
Why?
|
| Insulin-Secreting Cells | 3 | 2024 | 195 | 0.230 |
Why?
|
| Antigens, Neoplasm | 1 | 2026 | 136 | 0.230 |
Why?
|
| Immunologic Surveillance | 1 | 2025 | 22 | 0.230 |
Why?
|
| Iron-Binding Proteins | 1 | 2025 | 12 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2026 | 215 | 0.230 |
Why?
|
| Friedreich Ataxia | 1 | 2025 | 8 | 0.230 |
Why?
|
| rho-Associated Kinases | 1 | 2025 | 18 | 0.230 |
Why?
|
| DNA, Single-Stranded | 2 | 2025 | 107 | 0.230 |
Why?
|
| DNA, Mitochondrial | 2 | 2025 | 86 | 0.230 |
Why?
|
| Colony-Forming Units Assay | 1 | 2025 | 26 | 0.230 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 407 | 0.230 |
Why?
|
| Erythroid Cells | 1 | 2025 | 13 | 0.230 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2025 | 5 | 0.220 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2025 | 8 | 0.220 |
Why?
|
| Nuclear Envelope | 1 | 2025 | 49 | 0.220 |
Why?
|
| Gene Knock-In Techniques | 1 | 2025 | 48 | 0.220 |
Why?
|
| Galactosyltransferases | 1 | 2025 | 15 | 0.220 |
Why?
|
| Genome, Human | 4 | 2018 | 237 | 0.220 |
Why?
|
| Intracellular Membranes | 2 | 2015 | 46 | 0.220 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2025 | 46 | 0.220 |
Why?
|
| Sarcoma, Ewing | 1 | 2025 | 13 | 0.220 |
Why?
|
| Erythroid Precursor Cells | 1 | 2025 | 25 | 0.220 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2025 | 169 | 0.220 |
Why?
|
| CRISPR-Associated Proteins | 2 | 2015 | 32 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2024 | 23 | 0.220 |
Why?
|
| Neuropilin-1 | 1 | 2024 | 13 | 0.220 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2024 | 5 | 0.210 |
Why?
|
| CD24 Antigen | 1 | 2024 | 18 | 0.210 |
Why?
|
| Mesoderm | 4 | 2019 | 89 | 0.210 |
Why?
|
| Sertoli Cells | 2 | 2021 | 13 | 0.210 |
Why?
|
| LIM Domain Proteins | 1 | 2024 | 32 | 0.210 |
Why?
|
| Blood Platelet Disorders | 1 | 2023 | 4 | 0.210 |
Why?
|
| Ribonucleoproteins | 3 | 2022 | 116 | 0.210 |
Why?
|
| Endoplasmic Reticulum | 2 | 2015 | 176 | 0.200 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2023 | 9 | 0.200 |
Why?
|
| Bone Neoplasms | 1 | 2025 | 121 | 0.200 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2023 | 10 | 0.200 |
Why?
|
| Gene Ontology | 2 | 2020 | 38 | 0.200 |
Why?
|
| Telomerase | 2 | 2014 | 30 | 0.200 |
Why?
|
| NF-kappa B | 3 | 2017 | 434 | 0.200 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2015 | 52 | 0.200 |
Why?
|
| Nitric Oxide | 1 | 2024 | 164 | 0.200 |
Why?
|
| Adaptation, Physiological | 1 | 2024 | 129 | 0.200 |
Why?
|
| Male | 21 | 2026 | 31017 | 0.200 |
Why?
|
| Animals, Genetically Modified | 5 | 2022 | 310 | 0.200 |
Why?
|
| RNA Interference | 6 | 2021 | 643 | 0.200 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2014 | 35 | 0.200 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 45 | 0.200 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2013 | 46 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 3 | 2014 | 428 | 0.190 |
Why?
|
| Algorithms | 3 | 2020 | 1048 | 0.190 |
Why?
|
| Immunotherapy | 4 | 2026 | 274 | 0.190 |
Why?
|
| Position-Specific Scoring Matrices | 2 | 2020 | 6 | 0.190 |
Why?
|
| Subcutaneous Fat | 2 | 2020 | 50 | 0.190 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 350 | 0.190 |
Why?
|
| Phagocytosis | 1 | 2024 | 257 | 0.190 |
Why?
|
| Genes, cdc | 1 | 2022 | 15 | 0.190 |
Why?
|
| Phosphoproteins | 3 | 2020 | 224 | 0.190 |
Why?
|
| Thermogenesis | 5 | 2026 | 127 | 0.190 |
Why?
|
| Muscle, Skeletal | 2 | 2026 | 773 | 0.190 |
Why?
|
| Epithelial Cells | 3 | 2019 | 410 | 0.190 |
Why?
|
| Iron | 2 | 2021 | 154 | 0.180 |
Why?
|
| ATP-Dependent Proteases | 1 | 2022 | 7 | 0.180 |
Why?
|
| Gene Targeting | 2 | 2015 | 77 | 0.180 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2025 | 203 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2020 | 213 | 0.180 |
Why?
|
| Cytokines | 1 | 2026 | 952 | 0.180 |
Why?
|
| Gene Expression Regulation, Fungal | 5 | 2025 | 127 | 0.180 |
Why?
|
| Conserved Sequence | 2 | 2020 | 173 | 0.180 |
Why?
|
| Receptors, Erythropoietin | 1 | 2021 | 10 | 0.180 |
Why?
|
| Adipocytes, Brown | 2 | 2022 | 46 | 0.180 |
Why?
|
| Cell Nucleus | 3 | 2025 | 630 | 0.180 |
Why?
|
| Obesity | 3 | 2022 | 1267 | 0.180 |
Why?
|
| Unfolded Protein Response | 2 | 2021 | 61 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 3 | 2021 | 128 | 0.180 |
Why?
|
| Triglycerides | 2 | 2000 | 248 | 0.180 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 644 | 0.180 |
Why?
|
| Cell Size | 1 | 2021 | 41 | 0.180 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 156 | 0.180 |
Why?
|
| Fatty Liver | 2 | 2017 | 111 | 0.180 |
Why?
|
| Cell Survival | 6 | 2021 | 587 | 0.180 |
Why?
|
| Hedgehog Proteins | 2 | 2025 | 116 | 0.180 |
Why?
|
| Protein Biosynthesis | 2 | 2021 | 332 | 0.180 |
Why?
|
| Erythropoiesis | 1 | 2021 | 39 | 0.170 |
Why?
|
| Neisseria meningitidis | 2 | 2018 | 76 | 0.170 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 3 | 2018 | 99 | 0.170 |
Why?
|
| Endothelium | 2 | 2019 | 21 | 0.170 |
Why?
|
| Chromosomes, Human | 1 | 2021 | 52 | 0.170 |
Why?
|
| Erythrocytes | 1 | 2021 | 146 | 0.170 |
Why?
|
| Second Messenger Systems | 1 | 2021 | 27 | 0.170 |
Why?
|
| Dinoprostone | 1 | 2021 | 41 | 0.170 |
Why?
|
| Genes, X-Linked | 2 | 2021 | 22 | 0.170 |
Why?
|
| Trisomy | 1 | 2021 | 22 | 0.170 |
Why?
|
| RNA, Long Noncoding | 3 | 2025 | 171 | 0.160 |
Why?
|
| Epithelium | 3 | 2017 | 100 | 0.160 |
Why?
|
| Histone Acetyltransferases | 2 | 2012 | 59 | 0.160 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 17 | 0.160 |
Why?
|
| BRCA2 Protein | 1 | 2020 | 19 | 0.160 |
Why?
|
| Spermatogenesis | 1 | 2021 | 76 | 0.160 |
Why?
|
| Databases, Protein | 1 | 2020 | 45 | 0.160 |
Why?
|
| Aneuploidy | 1 | 2021 | 42 | 0.160 |
Why?
|
| Inactivation, Metabolic | 1 | 2020 | 14 | 0.160 |
Why?
|
| Oncogenes | 2 | 2017 | 70 | 0.160 |
Why?
|
| Acid-Base Equilibrium | 1 | 2000 | 7 | 0.160 |
Why?
|
| Cyclic AMP | 1 | 2021 | 144 | 0.160 |
Why?
|
| Glucagon | 1 | 2000 | 36 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 4 | 2025 | 88 | 0.160 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 156 | 0.160 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 50 | 0.160 |
Why?
|
| Cattle Diseases | 1 | 2000 | 11 | 0.160 |
Why?
|
| COUP Transcription Factor II | 1 | 2020 | 3 | 0.160 |
Why?
|
| Workflow | 1 | 2020 | 75 | 0.160 |
Why?
|
| Selenium | 1 | 2020 | 27 | 0.160 |
Why?
|
| Ammonia | 1 | 2000 | 16 | 0.160 |
Why?
|
| Huntington Disease | 1 | 2022 | 159 | 0.160 |
Why?
|
| Transcription Initiation Site | 2 | 2018 | 47 | 0.160 |
Why?
|
| 3' Untranslated Regions | 1 | 2020 | 95 | 0.160 |
Why?
|
| Golgi Apparatus | 1 | 2020 | 65 | 0.160 |
Why?
|
| Sequence Alignment | 1 | 2020 | 300 | 0.160 |
Why?
|
| Uveal Neoplasms | 1 | 2019 | 50 | 0.150 |
Why?
|
| Glutamine | 1 | 2000 | 50 | 0.150 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 225 | 0.150 |
Why?
|
| Veins | 1 | 2020 | 63 | 0.150 |
Why?
|
| Thermotolerance | 1 | 2019 | 2 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2013 | 178 | 0.150 |
Why?
|
| Splicing Factor U2AF | 2 | 2016 | 5 | 0.150 |
Why?
|
| Thiazolidines | 1 | 2019 | 14 | 0.150 |
Why?
|
| Integrin beta4 | 1 | 2019 | 35 | 0.150 |
Why?
|
| Heat-Shock Response | 1 | 2019 | 38 | 0.150 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 30 | 0.150 |
Why?
|
| Cerebral Cortex | 2 | 2018 | 268 | 0.150 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2019 | 49 | 0.150 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 76 | 0.150 |
Why?
|
| Mammary Glands, Human | 1 | 2019 | 56 | 0.150 |
Why?
|
| Mice, Transgenic | 6 | 2025 | 1287 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor C | 2 | 2016 | 21 | 0.150 |
Why?
|
| Receptors, Glucocorticoid | 3 | 2021 | 28 | 0.150 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2018 | 6 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2026 | 731 | 0.140 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 40 | 0.140 |
Why?
|
| Adenine | 1 | 2019 | 48 | 0.140 |
Why?
|
| Multiple Myeloma | 1 | 2024 | 369 | 0.140 |
Why?
|
| Mutagenesis, Insertional | 2 | 2018 | 94 | 0.140 |
Why?
|
| Carcinoma | 1 | 2019 | 130 | 0.140 |
Why?
|
| Huntingtin Protein | 2 | 2022 | 147 | 0.140 |
Why?
|
| Head | 1 | 2019 | 57 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2020 | 189 | 0.140 |
Why?
|
| Germ Cells | 1 | 2019 | 118 | 0.140 |
Why?
|
| Sequence Deletion | 1 | 2018 | 115 | 0.140 |
Why?
|
| Pseudomonas Infections | 1 | 2019 | 73 | 0.140 |
Why?
|
| Immunity, Innate | 1 | 2024 | 819 | 0.140 |
Why?
|
| Unified Medical Language System | 2 | 2009 | 6 | 0.140 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2018 | 16 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2026 | 863 | 0.140 |
Why?
|
| Receptors, Somatomedin | 1 | 2018 | 10 | 0.140 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2018 | 34 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2020 | 207 | 0.140 |
Why?
|
| Web Browser | 1 | 2018 | 7 | 0.140 |
Why?
|
| Protamines | 1 | 2018 | 6 | 0.140 |
Why?
|
| Transposases | 1 | 2018 | 18 | 0.140 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2018 | 27 | 0.140 |
Why?
|
| Polycomb-Group Proteins | 1 | 2018 | 21 | 0.140 |
Why?
|
| Embryonic Stem Cells | 3 | 2014 | 154 | 0.140 |
Why?
|
| Gene Transfer Techniques | 2 | 2017 | 325 | 0.140 |
Why?
|
| Ligases | 1 | 2018 | 27 | 0.140 |
Why?
|
| Homologous Recombination | 3 | 2025 | 28 | 0.140 |
Why?
|
| Transfection | 5 | 2019 | 701 | 0.140 |
Why?
|
| Carcinoma, Lobular | 1 | 2018 | 26 | 0.140 |
Why?
|
| Brain | 2 | 2024 | 1603 | 0.140 |
Why?
|
| Disease Progression | 5 | 2026 | 1219 | 0.140 |
Why?
|
| RNA Helicases | 1 | 2018 | 98 | 0.140 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2018 | 44 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2017 | 12 | 0.130 |
Why?
|
| Chromosome Mapping | 4 | 2020 | 295 | 0.130 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2018 | 61 | 0.130 |
Why?
|
| Genome, Bacterial | 2 | 2011 | 66 | 0.130 |
Why?
|
| Mitosis | 3 | 2025 | 222 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2023 | 132 | 0.130 |
Why?
|
| Mutagenesis | 1 | 2017 | 133 | 0.130 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2016 | 5 | 0.130 |
Why?
|
| Alternative Splicing | 2 | 2015 | 138 | 0.130 |
Why?
|
| Benzamides | 2 | 2014 | 69 | 0.130 |
Why?
|
| Blotting, Western | 6 | 2016 | 610 | 0.130 |
Why?
|
| Molecular Sequence Data | 3 | 2016 | 1979 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2022 | 509 | 0.130 |
Why?
|
| Ceramides | 2 | 2014 | 24 | 0.130 |
Why?
|
| Piperazines | 2 | 2014 | 86 | 0.120 |
Why?
|
| Intestines | 2 | 2020 | 178 | 0.120 |
Why?
|
| Longevity | 2 | 2015 | 117 | 0.120 |
Why?
|
| Anoikis | 1 | 2016 | 7 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2019 | 662 | 0.120 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2016 | 6 | 0.120 |
Why?
|
| RNA 3' End Processing | 1 | 2016 | 5 | 0.120 |
Why?
|
| beta Catenin | 1 | 2016 | 99 | 0.120 |
Why?
|
| Pyrimidines | 2 | 2014 | 145 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2016 | 3 | 0.120 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 160 | 0.120 |
Why?
|
| K562 Cells | 3 | 2022 | 58 | 0.120 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2016 | 17 | 0.120 |
Why?
|
| Lymphatic Vessels | 1 | 2016 | 32 | 0.120 |
Why?
|
| Substrate Specificity | 2 | 2014 | 341 | 0.120 |
Why?
|
| Mice, Nude | 4 | 2020 | 287 | 0.120 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 86 | 0.120 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 361 | 0.120 |
Why?
|
| Transcription Factor AP-1 | 1 | 2016 | 46 | 0.120 |
Why?
|
| Carrier Proteins | 3 | 2018 | 718 | 0.120 |
Why?
|
| Calcium | 3 | 2025 | 581 | 0.120 |
Why?
|
| RNA Precursors | 1 | 2016 | 78 | 0.120 |
Why?
|
| Neuropeptides | 1 | 2016 | 81 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 189 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 2 | 2016 | 113 | 0.110 |
Why?
|
| Up-Regulation | 4 | 2021 | 373 | 0.110 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2015 | 1 | 0.110 |
Why?
|
| Mammals | 3 | 2023 | 222 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2016 | 117 | 0.110 |
Why?
|
| Transcriptional Activation | 2 | 2015 | 197 | 0.110 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2016 | 93 | 0.110 |
Why?
|
| Neurons | 2 | 2018 | 933 | 0.110 |
Why?
|
| DNA Restriction Enzymes | 1 | 2014 | 34 | 0.110 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 33 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2016 | 103 | 0.110 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 3 | 0.110 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 7 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 111 | 0.110 |
Why?
|
| Gene Expression | 4 | 2020 | 852 | 0.110 |
Why?
|
| Jurkat Cells | 3 | 2019 | 109 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 4 | 2016 | 203 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 77 | 0.100 |
Why?
|
| RNA, Small Interfering | 5 | 2021 | 980 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2023 | 197 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 176 | 0.100 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 2 | 2025 | 15 | 0.100 |
Why?
|
| Single-Cell Analysis | 1 | 2015 | 115 | 0.100 |
Why?
|
| Oncogene Protein v-akt | 1 | 2013 | 15 | 0.100 |
Why?
|
| Erythropoietin | 2 | 2025 | 38 | 0.100 |
Why?
|
| Genetic Engineering | 2 | 2018 | 113 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2014 | 189 | 0.100 |
Why?
|
| Autophagy | 2 | 2016 | 234 | 0.100 |
Why?
|
| Bayes Theorem | 1 | 2013 | 125 | 0.100 |
Why?
|
| Nucleosomes | 1 | 2014 | 190 | 0.100 |
Why?
|
| User-Computer Interface | 2 | 2010 | 126 | 0.100 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 704 | 0.100 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 740 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 309 | 0.100 |
Why?
|
| TATA-Box Binding Protein | 1 | 2012 | 10 | 0.100 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 3 | 2019 | 16 | 0.100 |
Why?
|
| Olfactory Mucosa | 1 | 2012 | 4 | 0.100 |
Why?
|
| Point Mutation | 3 | 2019 | 168 | 0.100 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2012 | 18 | 0.100 |
Why?
|
| DNA Repair | 4 | 2020 | 262 | 0.090 |
Why?
|
| Sensory Receptor Cells | 1 | 2012 | 21 | 0.090 |
Why?
|
| Thioredoxins | 1 | 2012 | 17 | 0.090 |
Why?
|
| Lung | 2 | 2022 | 962 | 0.090 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2012 | 4 | 0.090 |
Why?
|
| Thrombopoietin | 1 | 2012 | 11 | 0.090 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 222 | 0.090 |
Why?
|
| Hydrops Fetalis | 1 | 2012 | 1 | 0.090 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2012 | 1 | 0.090 |
Why?
|
| Biomarkers | 4 | 2020 | 1477 | 0.090 |
Why?
|
| Genes, ras | 1 | 2012 | 28 | 0.090 |
Why?
|
| Prostatectomy | 2 | 2011 | 103 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 137 | 0.090 |
Why?
|
| HeLa Cells | 3 | 2020 | 541 | 0.090 |
Why?
|
| Chromosomes, Bacterial | 1 | 2011 | 43 | 0.090 |
Why?
|
| Models, Biological | 4 | 2021 | 1192 | 0.090 |
Why?
|
| Serine | 2 | 2022 | 90 | 0.090 |
Why?
|
| Imatinib Mesylate | 3 | 2019 | 34 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 3 | 2016 | 21 | 0.080 |
Why?
|
| Caulobacter crescentus | 1 | 2011 | 36 | 0.080 |
Why?
|
| Skin Neoplasms | 2 | 2014 | 407 | 0.080 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 555 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 178 | 0.080 |
Why?
|
| Lysine | 1 | 2011 | 94 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2010 | 71 | 0.080 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2010 | 24 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 181 | 0.080 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 295 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 3 | 2018 | 372 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 45 | 0.080 |
Why?
|
| Oligonucleotides | 2 | 2025 | 229 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 542 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 104 | 0.080 |
Why?
|
| Nuclear Lamina | 2 | 2020 | 10 | 0.080 |
Why?
|
| Gene Silencing | 2 | 2014 | 430 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2021 | 158 | 0.080 |
Why?
|
| Chromosomes | 1 | 2011 | 139 | 0.080 |
Why?
|
| Candidiasis | 1 | 2010 | 49 | 0.080 |
Why?
|
| Candida albicans | 1 | 2010 | 61 | 0.080 |
Why?
|
| Cattle | 2 | 2000 | 320 | 0.080 |
Why?
|
| Vimentin | 1 | 2009 | 19 | 0.070 |
Why?
|
| Glioma | 1 | 2010 | 101 | 0.070 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2021 | 51 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2020 | 161 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 61 | 0.070 |
Why?
|
| Alleles | 2 | 2022 | 453 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2016 | 426 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2012 | 352 | 0.070 |
Why?
|
| Genes, Reporter | 2 | 2022 | 257 | 0.070 |
Why?
|
| DNA Damage | 2 | 2021 | 298 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 237 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2016 | 261 | 0.070 |
Why?
|
| Inclusion Bodies | 1 | 2007 | 17 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 2 | 2019 | 243 | 0.070 |
Why?
|
| Bacteria | 1 | 2010 | 336 | 0.070 |
Why?
|
| Motor Neuron Disease | 1 | 2007 | 28 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2021 | 236 | 0.060 |
Why?
|
| Medical Subject Headings | 1 | 2007 | 2 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2017 | 97 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 318 | 0.060 |
Why?
|
| Genes | 1 | 2007 | 90 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2007 | 104 | 0.060 |
Why?
|
| Hair Follicle | 1 | 2006 | 36 | 0.060 |
Why?
|
| In Situ Hybridization | 2 | 2016 | 213 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 62 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 286 | 0.060 |
Why?
|
| Natural Language Processing | 1 | 2007 | 57 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2007 | 65 | 0.060 |
Why?
|
| Programming Languages | 1 | 2005 | 13 | 0.060 |
Why?
|
| Integrin beta3 | 1 | 2025 | 8 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2025 | 22 | 0.060 |
Why?
|
| Liposomes | 1 | 2026 | 116 | 0.060 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2025 | 6 | 0.060 |
Why?
|
| Genome, Mitochondrial | 1 | 2025 | 13 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2025 | 26 | 0.060 |
Why?
|
| Base Pairing | 1 | 2025 | 44 | 0.060 |
Why?
|
| Recombinational DNA Repair | 1 | 2025 | 29 | 0.060 |
Why?
|
| Tumor Burden | 2 | 2016 | 75 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2026 | 219 | 0.060 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2024 | 9 | 0.060 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2024 | 11 | 0.050 |
Why?
|
| Diet, High-Fat | 2 | 2017 | 180 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2018 | 662 | 0.050 |
Why?
|
| Calcium Chloride | 1 | 2024 | 19 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2020 | 324 | 0.050 |
Why?
|
| Heterografts | 2 | 2014 | 66 | 0.050 |
Why?
|
| Fat Body | 1 | 2024 | 11 | 0.050 |
Why?
|
| Lipoprotein Lipase | 1 | 2024 | 13 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2024 | 61 | 0.050 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2024 | 24 | 0.050 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2024 | 47 | 0.050 |
Why?
|
| Amidohydrolases | 1 | 2024 | 35 | 0.050 |
Why?
|
| Uridine Diphosphate Xylose | 1 | 2023 | 6 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2026 | 710 | 0.050 |
Why?
|
| TRPC Cation Channels | 1 | 2023 | 13 | 0.050 |
Why?
|
| TRPC6 Cation Channel | 1 | 2023 | 8 | 0.050 |
Why?
|
| Genetic Therapy | 2 | 2026 | 838 | 0.050 |
Why?
|
| Lipase | 1 | 2024 | 52 | 0.050 |
Why?
|
| Integrin alpha6 | 1 | 2023 | 20 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2023 | 47 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2025 | 160 | 0.050 |
Why?
|
| Protein Engineering | 2 | 2018 | 85 | 0.050 |
Why?
|
| Dementia | 1 | 2007 | 280 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2016 | 302 | 0.050 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2023 | 17 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 415 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2023 | 169 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2026 | 531 | 0.050 |
Why?
|
| Dietary Fats | 1 | 2024 | 179 | 0.050 |
Why?
|
| Calcium Channels | 1 | 2023 | 103 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2024 | 240 | 0.050 |
Why?
|
| Macrophages | 2 | 2024 | 1037 | 0.050 |
Why?
|
| Adrenergic Agents | 1 | 2022 | 15 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 60 | 0.050 |
Why?
|
| Sphingosine | 1 | 2022 | 20 | 0.050 |
Why?
|
| Adipocytes | 2 | 2015 | 273 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2022 | 58 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2024 | 196 | 0.050 |
Why?
|
| Fusobacterium nucleatum | 1 | 2002 | 4 | 0.050 |
Why?
|
| DNA Polymerase gamma | 1 | 2022 | 4 | 0.050 |
Why?
|
| Biotinylation | 1 | 2022 | 36 | 0.050 |
Why?
|
| Erythroblasts | 1 | 2021 | 15 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2021 | 24 | 0.040 |
Why?
|
| Reticulocytes | 1 | 2021 | 12 | 0.040 |
Why?
|
| Nucleotides | 2 | 2018 | 48 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2022 | 66 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2021 | 32 | 0.040 |
Why?
|
| Receptors, Transferrin | 1 | 2021 | 33 | 0.040 |
Why?
|
| Biotin | 1 | 2022 | 54 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 72 | 0.040 |
Why?
|
| Luciferases | 2 | 2012 | 107 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2026 | 673 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2016 | 869 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2022 | 154 | 0.040 |
Why?
|
| Anaphase | 1 | 2021 | 35 | 0.040 |
Why?
|
| Fetus | 1 | 2021 | 102 | 0.040 |
Why?
|
| Phenotype | 1 | 2025 | 1231 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 896 | 0.040 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2021 | 5 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2021 | 12 | 0.040 |
Why?
|
| CD4 Antigens | 1 | 2021 | 149 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2021 | 12 | 0.040 |
Why?
|
| Colforsin | 1 | 2021 | 25 | 0.040 |
Why?
|
| Chromogranins | 1 | 2021 | 12 | 0.040 |
Why?
|
| Radiation Chimera | 1 | 2021 | 61 | 0.040 |
Why?
|
| Genes, BRCA2 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Immunoblotting | 2 | 2012 | 202 | 0.040 |
Why?
|
| DNA, Fungal | 2 | 2012 | 58 | 0.040 |
Why?
|
| Proteolysis | 1 | 2022 | 154 | 0.040 |
Why?
|
| Child | 2 | 2021 | 4612 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2021 | 71 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 153 | 0.040 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2020 | 6 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2021 | 162 | 0.040 |
Why?
|
| Ammonium Chloride | 1 | 2000 | 10 | 0.040 |
Why?
|
| Arginase | 1 | 2000 | 7 | 0.040 |
Why?
|
| Phosphotransferases | 1 | 2020 | 22 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2021 | 342 | 0.040 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2000 | 4 | 0.040 |
Why?
|
| Selenocysteine | 1 | 2020 | 15 | 0.040 |
Why?
|
| Middle Aged | 5 | 2019 | 18254 | 0.040 |
Why?
|
| Selenium Compounds | 1 | 2020 | 30 | 0.040 |
Why?
|
| Choline Deficiency | 1 | 2000 | 14 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2021 | 100 | 0.040 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2000 | 52 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2020 | 59 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 241 | 0.040 |
Why?
|
| Multivesicular Bodies | 1 | 2019 | 5 | 0.040 |
Why?
|
| Ferritins | 1 | 2019 | 30 | 0.040 |
Why?
|
| Labor, Obstetric | 1 | 2000 | 35 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2020 | 130 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1006 | 0.040 |
Why?
|
| Granulosa Cells | 1 | 2019 | 18 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2014 | 1162 | 0.040 |
Why?
|
| Platinum | 1 | 2019 | 20 | 0.040 |
Why?
|
| Neuropilins | 1 | 2019 | 8 | 0.040 |
Why?
|
| Protein Transport | 1 | 2021 | 404 | 0.040 |
Why?
|
| bcl-Associated Death Protein | 1 | 2019 | 10 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2020 | 128 | 0.040 |
Why?
|
| Leukemia, Experimental | 1 | 2019 | 19 | 0.040 |
Why?
|
| Lactation | 1 | 2000 | 78 | 0.040 |
Why?
|
| Pericytes | 1 | 2019 | 17 | 0.040 |
Why?
|
| Nuclear Localization Signals | 1 | 2019 | 20 | 0.040 |
Why?
|
| STAT Transcription Factors | 1 | 2019 | 17 | 0.040 |
Why?
|
| Inverted Repeat Sequences | 1 | 2019 | 14 | 0.040 |
Why?
|
| Ovarian Follicle | 1 | 2019 | 39 | 0.040 |
Why?
|
| Eating | 1 | 2000 | 137 | 0.040 |
Why?
|
| Pregnancy | 2 | 2012 | 2374 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 44 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2019 | 90 | 0.040 |
Why?
|
| Melanocytes | 1 | 2019 | 77 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2000 | 497 | 0.040 |
Why?
|
| Weight Gain | 1 | 2000 | 166 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 49 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2019 | 81 | 0.040 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2018 | 3 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 148 | 0.040 |
Why?
|
| Azepines | 1 | 2018 | 22 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 29 | 0.040 |
Why?
|
| Multifunctional Enzymes | 1 | 2018 | 19 | 0.030 |
Why?
|
| Plasmids | 1 | 2019 | 294 | 0.030 |
Why?
|
| Muscle Cells | 1 | 2018 | 28 | 0.030 |
Why?
|
| Hydrolases | 1 | 2019 | 82 | 0.030 |
Why?
|
| Swine | 1 | 2019 | 394 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2018 | 30 | 0.030 |
Why?
|
| Sumoylation | 1 | 2018 | 17 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2017 | 9 | 0.030 |
Why?
|
| Triazoles | 1 | 2018 | 63 | 0.030 |
Why?
|
| Protein Stability | 1 | 2018 | 96 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2018 | 56 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 132 | 0.030 |
Why?
|
| Proprotein Convertase 9 | 1 | 2017 | 15 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2017 | 6 | 0.030 |
Why?
|
| Core Binding Factor beta Subunit | 1 | 2017 | 22 | 0.030 |
Why?
|
| Cell Separation | 1 | 2018 | 147 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2017 | 105 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 180 | 0.030 |
Why?
|
| Time Factors | 2 | 2016 | 3762 | 0.030 |
Why?
|
| Organelle Biogenesis | 1 | 2017 | 19 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2018 | 96 | 0.030 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2017 | 29 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2019 | 222 | 0.030 |
Why?
|
| Leukemia | 1 | 2017 | 62 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2017 | 41 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 190 | 0.030 |
Why?
|
| Proteome | 1 | 2018 | 152 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2018 | 232 | 0.030 |
Why?
|
| Aged | 4 | 2018 | 14946 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 464 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 5607 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 21 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2016 | 28 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1187 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 182 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 80 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 195 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2018 | 198 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 90 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 544 | 0.030 |
Why?
|
| Kruppel-Like Factor 6 | 1 | 2016 | 3 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2018 | 256 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 311 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 218 | 0.030 |
Why?
|
| DNA Cleavage | 1 | 2015 | 18 | 0.030 |
Why?
|
| Uncoupling Protein 1 | 1 | 2015 | 51 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 219 | 0.030 |
Why?
|
| Wolfram Syndrome | 1 | 2015 | 1 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 524 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 7 | 0.030 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2015 | 11 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 50 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2016 | 141 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2015 | 22 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2016 | 141 | 0.030 |
Why?
|
| Ion Channels | 1 | 2015 | 92 | 0.030 |
Why?
|
| Viruses | 1 | 2016 | 81 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 152 | 0.030 |
Why?
|
| Palmitates | 1 | 2015 | 20 | 0.030 |
Why?
|
| Membrane Lipids | 1 | 2015 | 25 | 0.030 |
Why?
|
| raf Kinases | 1 | 2014 | 4 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2014 | 42 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2014 | 4 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 65 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 204 | 0.030 |
Why?
|
| Chromones | 1 | 2014 | 18 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2014 | 99 | 0.030 |
Why?
|
| Genes, Neoplasm | 1 | 2014 | 25 | 0.030 |
Why?
|
| Sirtuin 3 | 1 | 2014 | 11 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 58 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 673 | 0.030 |
Why?
|
| Aging | 1 | 2000 | 766 | 0.030 |
Why?
|
| Acetylation | 1 | 2014 | 121 | 0.030 |
Why?
|
| Exons | 1 | 2015 | 205 | 0.030 |
Why?
|
| Gene Library | 1 | 2014 | 102 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 91 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 2014 | 102 | 0.030 |
Why?
|
| Body Weight | 1 | 2015 | 374 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2014 | 88 | 0.030 |
Why?
|
| Movement | 1 | 2015 | 163 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 51 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 289 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 89 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2014 | 81 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 64 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 17 | 0.020 |
Why?
|
| Zinc Finger Protein Gli3 | 1 | 2013 | 10 | 0.020 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2013 | 26 | 0.020 |
Why?
|
| Molting | 1 | 2013 | 9 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2014 | 136 | 0.020 |
Why?
|
| Betaproteobacteria | 1 | 2013 | 6 | 0.020 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2013 | 10 | 0.020 |
Why?
|
| Starvation | 1 | 2013 | 11 | 0.020 |
Why?
|
| Smoothened Receptor | 1 | 2013 | 27 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 17351 | 0.020 |
Why?
|
| Glycolysis | 1 | 2013 | 59 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 173 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 576 | 0.020 |
Why?
|
| Lipolysis | 1 | 2013 | 47 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 43 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2012 | 9 | 0.020 |
Why?
|
| RUNX1 Translocation Partner 1 Protein | 1 | 2012 | 11 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 367 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2012 | 30 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2012 | 33 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 108 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 239 | 0.020 |
Why?
|
| Galactokinase | 1 | 2012 | 3 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2012 | 37 | 0.020 |
Why?
|
| Metaplasia | 1 | 2012 | 19 | 0.020 |
Why?
|
| Galactose | 1 | 2012 | 12 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 151 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 198 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 74 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 140 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 260 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2012 | 152 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2012 | 181 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 48 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2011 | 30 | 0.020 |
Why?
|
| Biological Assay | 1 | 2012 | 56 | 0.020 |
Why?
|
| Molecular Docking Simulation | 1 | 2012 | 81 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 388 | 0.020 |
Why?
|
| Fluorescence | 1 | 2012 | 93 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2011 | 43 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 211 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 447 | 0.020 |
Why?
|
| DNA, Intergenic | 1 | 2011 | 24 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 233 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2012 | 176 | 0.020 |
Why?
|
| Sirolimus | 1 | 2011 | 93 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 274 | 0.020 |
Why?
|
| Methylation | 1 | 2011 | 130 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 450 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2010 | 14 | 0.020 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2010 | 24 | 0.020 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2012 | 263 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 33 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2010 | 32 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2011 | 513 | 0.020 |
Why?
|
| Vocabulary, Controlled | 1 | 2010 | 4 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 168 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 791 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 844 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 47 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2009 | 22 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 128 | 0.020 |
Why?
|
| Keratin-18 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Lentivirus | 1 | 2009 | 64 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 119 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2016 | 917 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 39 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 70 | 0.020 |
Why?
|
| Diet | 1 | 2013 | 534 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 380 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 483 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 1589 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 676 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 382 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2013 | 714 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 251 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 401 | 0.020 |
Why?
|
| Axonemal Dyneins | 1 | 2007 | 5 | 0.020 |
Why?
|
| Annexin A2 | 1 | 2007 | 7 | 0.020 |
Why?
|
| MEDLINE | 1 | 2007 | 13 | 0.020 |
Why?
|
| Database Management Systems | 1 | 2007 | 20 | 0.020 |
Why?
|
| Software Design | 1 | 2007 | 28 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 84 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 372 | 0.020 |
Why?
|
| Dyneins | 1 | 2007 | 112 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 128 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2007 | 203 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2007 | 60 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2006 | 71 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1113 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 1989 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 195 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1141 | 0.010 |
Why?
|
| Internet | 1 | 2007 | 468 | 0.010 |
Why?
|
| Coenzymes | 1 | 2002 | 7 | 0.010 |
Why?
|
| Protons | 1 | 2002 | 67 | 0.010 |
Why?
|
| Virulence | 1 | 2002 | 199 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2002 | 96 | 0.010 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2002 | 127 | 0.010 |
Why?
|
| Biological Transport | 1 | 2002 | 292 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2002 | 261 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 624 | 0.010 |
Why?
|